- Home
- ARVN vs SIFY Comparison
ARVN vs SIFY Comparison
Compare ARVN & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- SIFY
- Stock Information
- Founded
- ARVN 2015
- SIFY 1995
- Country
- ARVN United States
- SIFY India
- Employees
- ARVN N/A
- SIFY N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- SIFY Computer Software: Programming Data Processing
- Sector
- ARVN Health Care
- SIFY Technology
- Exchange
- ARVN Nasdaq
- SIFY Nasdaq
- Market Cap
- ARVN 456.2M
- SIFY 369.1M
- IPO Year
- ARVN 2018
- SIFY 1999
- Fundamental
- Price
- ARVN $7.81
- SIFY $4.87
- Analyst Decision
- ARVN Buy
- SIFY
- Analyst Count
- ARVN 21
- SIFY 0
- Target Price
- ARVN $20.53
- SIFY N/A
- AVG Volume (30 Days)
- ARVN 1.8M
- SIFY 35.2K
- Earning Date
- ARVN 07-29-2025
- SIFY 07-18-2025
- Dividend Yield
- ARVN N/A
- SIFY N/A
- EPS Growth
- ARVN N/A
- SIFY N/A
- EPS
- ARVN N/A
- SIFY N/A
- Revenue
- ARVN $426,900,000.00
- SIFY $466,789,000.00
- Revenue This Year
- ARVN $7.57
- SIFY N/A
- Revenue Next Year
- ARVN N/A
- SIFY $13.46
- P/E Ratio
- ARVN N/A
- SIFY N/A
- Revenue Growth
- ARVN 498.74
- SIFY 11.93
- 52 Week Low
- ARVN $5.90
- SIFY $1.84
- 52 Week High
- ARVN $34.11
- SIFY $5.71
- Technical
- Relative Strength Index (RSI)
- ARVN 54.65
- SIFY 52.48
- Support Level
- ARVN $7.58
- SIFY $4.55
- Resistance Level
- ARVN $8.31
- SIFY $4.88
- Average True Range (ATR)
- ARVN 0.39
- SIFY 0.20
- MACD
- ARVN 0.03
- SIFY 0.03
- Stochastic Oscillator
- ARVN 64.75
- SIFY 75.99
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.